Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

2022237 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Nature Medicine

Volume 28, Issue 1, pp. 144-153

Field-Weighted Citation Impact: 33.49